| Descriptor English: | Dyskinesia, Drug-Induced | ||||||
| Descriptor Spanish: |
Discinesia Inducida por Medicamentos
| ||||||
| Descriptor Portuguese: | Discinesia Induzida por Medicamentos | ||||||
| Descriptor French: | Dyskinésie due aux médicaments | ||||||
| Entry term(s): |
Drug-Induced Dyskinesia Drug-Induced Dyskinesias Dyskinesia, Drug Induced Dyskinesia, Medication Induced Dyskinesia, Medication-Induced Dyskinesias, Drug-Induced Dyskinesias, Medication-Induced Medication Induced Dyskinesia Medication-Induced Dyskinesia Medication-Induced Dyskinesias |
||||||
| Tree number(s): |
C10.228.662.262.500 C10.597.350.275 C10.720.312 C23.888.592.350.275 C25.100.750 C25.723.705.200 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004409 | ||||||
| Scope note: | Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) |
||||||
| Annotation: | do not confuse with AKATHISIA, DRUG-INDUCED |
||||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
| Previous Indexing: |
Movement Disorders (1966-1976) |
||||||
| Public MeSH Note: | 77 |
||||||
| History Note: | 77 |
||||||
| Entry Version: | DYSKINESIA DRUG IND |
||||||
| Related: |
Akathisia, Drug-Induced
MeSH | ||||||
| DeCS ID: | 4472 | ||||||
| Unique ID: | D004409 | ||||||
| NLM Classification: | WL 390 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1977/01/01 | ||||||
| Date of Entry: | 1976/05/19 | ||||||
| Revision Date: | 2016/01/20 |
|
|
Dyskinesia, Drug-Induced
- Preferred
Dyskinesia, Medication-Induced
- Narrower
| Concept UI |
M0006920 |
| Scope note | Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) |
| Preferred term | Dyskinesia, Drug-Induced |
| Entry term(s) |
Drug-Induced Dyskinesia Drug-Induced Dyskinesias Dyskinesia, Drug Induced Dyskinesias, Drug-Induced |
| Concept UI |
M0335655 |
| Preferred term | Dyskinesia, Medication-Induced |
| Entry term(s) |
Dyskinesia, Medication Induced Dyskinesias, Medication-Induced Medication Induced Dyskinesia Medication-Induced Dyskinesia Medication-Induced Dyskinesias |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
